NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy

Front Immunol. 2024 Dec 6:15:1503857. doi: 10.3389/fimmu.2024.1503857. eCollection 2024.

Abstract

Introduction: Extracellular vesicles of Natural Killer cells (NKEV) exert an antitumor effect towards hematopoietic and solid tumors and have an immune modulating effect, suggesting a promising role in immune and biotherapy. In this study, a continuation of our former works, we demonstrated a network by mass spectrometry analysis between NKEV protein cargo and antitumor effects. Human healthy NKEV, both exosomes and microvesicles, have a significant and direct cytotoxic effect against human B cell lymphoma in in vitro and in vivo conditions.

Methods: We isolated extracellular vesicles from in vitro amplified healthy human NK cells and their treatment efficacy was monitored by cytometry analyses, in vivo MRI/MRS measurements, ex vivo MRS analyses and immunohistochemistry.

Results: We observed a remarkable NKEV cytotoxic effect, mainly by apoptosis, on B cell lymphoma in vitro when exosomes and microvesicles were administered simultaneously. In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo 1H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. Ex vivo lymphoma metabolomics revealed a significant increase in fatty acid (FA) pool and decrease in unsaturated and mono-unsaturated FA in treated groups, as compared to control one, thus suggesting an alteration of tumor homeostasis. Immunohistochemistry analyses confirmed the reduction of B-cell lymphoma proliferation rate, as well as the induction of apoptosis following the NKEV treatment.

Conclusions: This study underscore the importance of NKEV as a novel biological acellular tool for B-cell lymphoma treatment, probably having a greater effect on combined treatment regimens. These nanovesicles have an extraordinary potential in innovative cancer immunotherapy, representing a safe and efficient tool naturally circulating in healthy individuals and ready to maintain the immune homeostasis, and therefore a good organism healthy state.

Keywords: B cell lymphoma; NK cells; biotherapy; exosomes; extracellular vesicles; immunotherapy; microvesicles.

MeSH terms

  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Exosomes / immunology
  • Exosomes / metabolism
  • Extracellular Vesicles* / immunology
  • Extracellular Vesicles* / metabolism
  • Female
  • Humans
  • Killer Cells, Natural* / immunology
  • Lymphoma, B-Cell* / immunology
  • Lymphoma, B-Cell* / metabolism
  • Lymphoma, B-Cell* / therapy
  • Mice
  • Mice, SCID*
  • Xenograft Model Antitumor Assays*

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by funds from Ministero della Salute, Italy, WFR GR-2011-02351400 (LL) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.